Marc S. Kurzweil Counsel

New York
T 646.414.6921 | F 973.535.3321



Marc’s clients include international and U.S.-based lenders and borrowers from a range of industries, including insurance, paper and forest products, pharmaceuticals, real estate, financial services, telecommunications, manufacturing, health care, art, technology, and diamonds and jewelry.

Marc represents agent banks, lenders, corporate borrowers, private equity funds, hedge funds, real estate investment trusts (REITs), and high-net-worth individuals in a variety of complex financing transactions, including:

  • Syndicated and bilateral term and revolving credit facilities
  • Acquisition financings
  • Asset-based and cash flow financings
  • Capital call subscription credit facilities
  • Working capital facilities
  • First and second lien financings
  • Subordinated debt facilities
  • Unitranche and mezzanine financings
  • Recapitalization and other leveraged financings
  • Real estate financings
  • Letter of credit facilities

Representative Engagements

Represented Tower International, Inc. (NYSE: TOWR), and its subsidiaries, in a $561.5 million refinancing consisting of a $361.5 million term loan facility agented by Citibank, N.A. and a $200 million revolving credit facility agented by JPMorgan Chase Bank, N.A.

Other Distinctions

Super Lawyers (2015) – Recognized as a "Rising Star."

Press Mentions

Lowenstein Sandler represented Moelis Capital Partners in its investment in Flexible Architecture and Simplified Technology (FAST), which is a leading provider of software solutions for the insurance industry. FAST is recognized as a leader in technology within the US marketplace, and is well-positioned to serve its customers through this deal. Terms of the investment were not disclosed. The Lowenstein deal team included Christopher Henry, Jonathan Goodman, Kimberly Donnelly Rowe, Sarah Saladini, Marc Kurzweil, Vanessa Ignacio, John Wintermute, Michael Walutes, Lesley Adamo, Jim Gregory, and Stuart Yusem. , September 9, 2015
Lowenstein Sandler represented Pernix Therapeutics Holdings Inc. in its acquisition of the Zohydro® ER Franchise from Zogenix Inc. Under terms of the agreement, Pernix, through its wholly-owned subsidiary, Ferrimill Limited, paid Zogenix $70 million in cash, issued to Zogenix 1,682,086 shares of Pernix common stock and deposited an additional $10 million in cash in escrow to fund potential indemnification claims for a period of 12 months following the closing. Pernix also purchased certain Zohydro ER inventory. The Lowenstein deal team is led by Michael Lerner, Herschel Weinstein, and Park Bramhall, and also included Lowell A. Citron, Marc Kurzweil, Brian A. Silikovitz, Christina Iafe, Jack D. Sidorov, Jeffrey M. Shapiro, Hilla Shimshoni, Tara P. D'Orsi, Michael Amalfe, Sarah Saladini and Eugene Cheval. , April 24, 2015

Related Areas

Corporate
Debt Finance
Transactions & Advisory Group

Education


Fordham University School of Law ( L.L.M , 2006 ) , Staff Member, Journal of Corporate and Financial Law
New York Law School ( J.D. , 2005 ) , Staff Editor, Media Law and Policy Journal
George Washington University ( B.B.A. , 2002 ) , Dean’s List

Bar Admissions


New York
New Jersey

Affiliations


  • Member, New York State Bar Association 
  • Member, American Bar Association